期刊文献+

妊娠期肝内胆汁淤积症孕妇血清甘胆酸水平对母儿预后的影响 被引量:3

Effects of serum cholyglycine on the prognosis of perineonate and mother with intrahepatic cholestosis during pregnancy
原文传递
导出
摘要 目的探讨妊娠期肝内胆汁淤积症(ICP)孕妇血清甘胆酸(CG)水平对母婴结局的影响。方法回顾性分析82例ICP患者的临床资料,按CG水平分为轻型组(CG<27 mg/L)和重型组(CG≥27 mg/L),比较两组母婴相关临床资料。结果重型组胎儿羊水污染率、新生儿窒息率、新生儿低体重率、早产率、死胎率分别为44.2%、11.6%、32.6%、58.1%、7.0%,显著高于轻型组的12.8%、2.6%、10.3%、17.9%、0%,除新生儿窒息率外,差异均有统计学意义(P<0.05)。重型组孕妇剖宫产率、肝功能异常率和产后出血率分别为93.0%、76.7%、39.5%,显著高于轻型组的64.1%、28.2%、17.9%(P<0.05)。结论血清CG水平是预测ICP母儿预后的重要指标。 Objective To investigate the effects of serum cholyglycine(CG) on the prognosis of perineonate and mother with intrahepatic cholestosis of pregnancy(ICP).Methods Data of 82 ICP cases were retrospectively analyzed.The patients were divided into two groups of A(CG27mg/L) and B(CG≥27mg/L).The related clinical outcomes of perineonate and mother were compared.Results The incidence rates of meconium in amnion,low birth weight of infant,preterm birth and fetus death in group B were 44.2%,32.6%,58.1% and 7.0%,respectively,which were significantly higher than 12.8%,10.3%,17.9% and 0% in group A(P0.05).The incidence rates of cesarean section,liver dysfunction and postpartum hemorrhage in group B were 93.0%,76.7% and 39.5%,which were significantly higher than 64.1%,28.2% and 17.9% in group A(P0.05).ConclusionSerum level of CG may predict the prognosis of patients with ICP.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第22期2618-2619,共2页 Jiangsu Medical Journal
基金 南京市科技发展计划(YKK08120)
关键词 妊娠期肝内胆汁淤积症 甘胆酸 Intrahepatic cholestasis of pregnancy Glycocholic acid
  • 相关文献

参考文献5

二级参考文献68

  • 1周克碧,施云秋.妊娠期肝内胆汁淤积症182例临床分析[J].现代医药卫生,2005,21(11):1348-1349. 被引量:10
  • 2[29]Egerman RS,Riely CA.Predicting fetal outcome in intrahepatic cholestasis of pregnancy:is the bile acid level sufficient? Hepatology 2004; 40:287-288
  • 3[30]Meng LJ,Reyes H,Axelson M,Palma J,Hernandez I,Ribalta J,Sjovall J.Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy:effect of ursodeoxycholic acid therapy.Hepatology 1997; 26:1573-1579
  • 4[31]Palma J,Reyes H,Ribalta J,Hernandez I,Sandoval L,Almuna R,Liepins J,Lira F,Sedano M,Silva O,Toha D,Silva JJ.Ursodeoxycholic acid in the treatment of cholestasis of pregnancy:a randomized,double-blind study controlled with placebo.J Hepatol 1997; 27:1022-1028
  • 5[32]Mazzella G,Rizzo N,Azzaroli F,Simoni P,Bovicelli L,Miracolo A,Simonazzi G,Colecchia A,Nigro G,Mwangemi C,Festi D,Roda E.Ursodeoxycholic acid administration in patients with cholestasis of pregnancy:effects on primary bile acids in babies and mothers.Hepatology 2001; 33:504-508
  • 6[33]Zapata R,Sandoval L,Palma J,Hernandez I,Ribalta J,Reyes H,Sedano M,Toha D,Silva JJ.Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy.A 12-year experience.Liver Int 2005; 25:548-554
  • 7[34]Glantz A,Marschall HU,Lammert F,Mattsson LA.Intrahepatic cholestasis of pregnancy:a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.Hepatology 2005; 42:1399-1405
  • 8[1]Riely CA,Bacq Y.Intrahepatic cnolestasis ot pregnancy.Clin Liver Dis 2004; 8:167-176
  • 9[2]Lammert F,Marschall HU,Glantz A,Matern S.Intrahepatic cholestasis of pregnancy:molecular pathogenesis,diagnosis and management.J Hepatol 2000; 33:1012-1021
  • 10[3]Glantz A,Marschall HU,Mattsson LA.Intrahepatic cholestasis of pregnancy:Relationships between bile acid levels and fetal complication rates.Hepatology 2004; 40:467-474

共引文献60

同被引文献33

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部